Skip to content

Cost-effectiveness threshold

Uncle Sam hitting a high striker with a large hammer. The high striker show a lambda at the top.

Cost-effectiveness thresholds under political pressure: where are the health economists?

The UK government is reportedly preparing to raise NICE’s cost-effectiveness threshold by 25%, as a bargaining chip to avoid US pharmaceutical tariffs. It’s time for health economists to reclaim this space and defend evidence-based decision-making.

Opportunity costs, marginal productivity, and cost-effectiveness thresholds: providing useful analysis and communicating results

In our first post, we explained opportunity cost, marginal productivity (of a healthcare system), net benefit, and cost-effectiveness threshold. In this post, we put forward our views on how to use cost-effectiveness thresholds and the existing estimates of marginal productivity… Read More »Opportunity costs, marginal productivity, and cost-effectiveness thresholds: providing useful analysis and communicating results

Opportunity costs, marginal productivity, and cost-effectiveness thresholds: what are they and how are they related?

In this post, we explain key concepts of cost-effectiveness analysis in healthcare and how they are linked: opportunity cost, marginal productivity (of a healthcare system), net benefit, and cost-effectiveness threshold. In another post, to be published tomorrow, we will propose… Read More »Opportunity costs, marginal productivity, and cost-effectiveness thresholds: what are they and how are they related?